2012
Mechanical dyssynchrony evaluated by tissue Doppler cross-correlation analysis is associated with long-term survival in patients after cardiac resynchronization therapy
Risum N, Williams ES, Khouri MG, Jackson KP, Olsen NT, Jons C, Storm KS, Velazquez EJ, Kisslo J, Bruun NE, Sogaard P. Mechanical dyssynchrony evaluated by tissue Doppler cross-correlation analysis is associated with long-term survival in patients after cardiac resynchronization therapy. European Heart Journal 2012, 34: 48-56. PMID: 22390911, DOI: 10.1093/eurheartj/ehs035.Peer-Reviewed Original ResearchMeSH KeywordsAgedArrhythmias, CardiacCardiac Resynchronization TherapyCardiac Resynchronization Therapy DevicesCross-Sectional StudiesDefibrillators, ImplantableFeasibility StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesStroke VolumeTreatment OutcomeUltrasonography, Doppler, ColorVentricular Dysfunction, LeftConceptsCardiac resynchronization therapyLong-term survivalMechanical dyssynchronyYu indexResynchronization therapyCox proportional hazards regressionLeft bundle branch blockProportional hazards regressionTissue Doppler imagingBundle branch blockPre-implant assessmentActivation delayVentricular assist deviceCardiac transplantationCause mortalityCRT candidatesImproved survivalHazards regressionPoor prognosisSubgroup analysisBranch blockWall delayPoor survivalDyssynchronyDoppler imaging
2008
Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or Both
Prisant LM, Thomas KL, Lewis EF, Huang Z, Francis GS, Weaver WD, Pfeffer MA, McMurray JJ, Califf RM, Velazquez EJ. Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or Both. Journal Of The American College Of Cardiology 2008, 51: 1865-1871. PMID: 18466801, DOI: 10.1016/j.jacc.2007.12.050.Peer-Reviewed Original ResearchMeSH KeywordsAngiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme InhibitorsBiomarkersBlack or African AmericanCaptoprilFemaleHeart FailureHospitalizationHumansIncidenceMaleMiddle AgedMyocardial InfarctionRetrospective StudiesRisk FactorsSystoleTetrazolesUnited StatesValineValsartanVentricular Dysfunction, LeftWhite PeopleConceptsLeft ventricular systolic dysfunctionHeart failureAcute myocardial infarctionMyocardial infarctionBaseline characteristicsAfrican AmericansMyocardial Infarction ComplicatedAngiotensin receptor blockersCoronary risk factorsOutcomes of patientsRecurrent myocardial infarctionVentricular systolic dysfunctionSimilar clinical outcomesHF hospitalizationCardiovascular morbidityCause mortalityReceptor blockersSystolic dysfunctionVentricular dysfunctionCardiovascular mortalityWhite patientsClinical outcomesPoor outcomeVALIANT trialSubgroup analysis